160eP Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving nivolumab

higher baseline Hb levels and improved survival further highlights the importance of host-related factors in determining immunotherapy outcomes.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2026-03-17
DOI
https://doi.org/10.1016/j.esmoop.2026.106467
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

160eP Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving nivolumab

Özgür Tanriverdi, A. Alkan, S. Kitapli
ESMO Open
Cancer Immunotherapy and Biomarkers
article

160eP Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving nivolumab

Özgür Tanriverdi, A. Alkan, S. Kitapli
article en

Abstract

higher baseline Hb levels and improved survival further highlights the importance of host-related factors in determining immunotherapy outcomes.

ESMO OpenVol. 11
Muğla University (TR)
Openalex Percentile: Top 18%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

160eP Exploring the prognostic value of the magnesium–immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving nivolumab — Özgür Tanriverdi, A. Alkan, et al. · ESMO Open (2026) | TGRS Research Map | TGRS